AGRX(Delisted)
Agile TherapeuticsยทNASDAQ
--
--(--)
AGRX Profile
Agile Therapeutics,Inc.
A forward-thinking women's healthcare company that develops prescription contraceptive products
500 College Road East, Suite 310, Princeton, New Jersey 08540
--
Agile Therapeutics, Inc., was incorporated in Delaware on December 22, 1997. The company is a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products. Agile's product candidates are designed to provide women with more convenient and compliant contraceptive options. Agile has developed a patented technology for transdermal patches called Skinfusion, which aims to provide better adhesion, stability and patient acceptance than currently available drug patches. The company's lead product candidate, Twirla, also known as AG200-15, is a once-a-week prescription contraceptive patch that is currently in Phase 3 clinical development. Currently, only one additional contraceptive patch is available in the United States, and the patch is limited due to its dosage and physical properties. And Twirla is designed to address these limitations.
